Screener/Healthcare/Biotechnology

LCTX

Lineage Cell Therapeutics, Inc.AMEX
$1.48+0.01 (+0.68%)
$0.37
$2.09
$1.42
$1.48
EPS (TTM)$-0.29
P/E Ratio
Dividend Yield
Market Cap$415.7M
Volume768K
Prev Close$1.47
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$3.7M-$29.8M$-0.13-808.3%
Q2 '25$2.8M-$30.4M$-0.13-1098.2%
Q1 '25$1.5M-$4.1M$-0.0297.6%-275.8%
Q4 '24$2.9M-$3.3M$-0.0194.6%-113.3%
Q3 '24$3.8M-$3.0M$-0.0299.0%-79.4%
Q2 '24$1.4M-$5.8M$-0.0396.9%-410.0%
Q1 '24$1.4M-$6.6M$-0.0493.2%-454.2%
Q4 '23$2.1M-$4.8M$-0.0387.7%-228.7%
Get Your Daily Market Recap